FDA
FDA Approves PADCEV and Keytruda Perioperative Therapy: A Game-Changer for Cisplatin-Ineligible Bladder Cancer Patients
2025-11-27
AbbVie Buys Bretisilocin from Gilgamesh in $1.2B Deal to Expand Depression Drug Pipeline–Another Win in the Psychedelic Space?
2025-08-27
Lilly Eyes Future of One-Time Cardiovascular Health with $1.3B Verve Therapeutics Acquisition
2025-06-18
LATEST
Study Explores Youth Perspectives on Integrating Physical Activity into Substance Use Treatment Programs
2026-01-24
HDAC6 Identified as Key Driver of Metastasis and Immunosuppression in Small Cell Lung Cancer Study
2026-01-24



